|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01061 ESSEX BIO-TECH
Nominal 
2.600 0.000 (0.000%) | 2023/12 - Final HKD(K$) | %Chg (Compare to Final) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | |
| Turnover | 1,706,556 | 29.509% | 1,317,711 | 1,637,659 | 978,111 | 1,279,478 |
| Cost of Sales | (167,263) | 30.286% | (128,382) | (241,893) | (184,284) | (246,124) |
| Gross Profit | 1,539,293 | 29.425% | 1,189,329 | 1,395,767 | 793,827 | 1,033,354 |
| 2023/12 - Final HKD(K$) | %Chg (Compare to Final) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (1,641) | 746.841% | (194) | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 346,014 | 32.907% | 260,343 | 394,457 | 250,855 | 351,765 | |
| Taxation | (70,755) | 102.553% | (34,931) | (48,489) | (31,929) | (49,263) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 275,260 | 22.114% | 225,411 | 345,968 | 218,926 | 302,502 | |
| 2023/12 - Final HKD(K$) | %Chg (Compare to Final) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | |
| Net Finance Costs / (Income) | (1,131) | -- | 2,594 | (636) | (6,159) | 3,366 |
| Depreciation & Amortisation | 59,876 | 42.859% | 41,913 | 32,971 | 27,599 | 27,797 |
| Directors' Emoluments | 8,331 | -3.067% | 8,594 | 9,616 | 8,478 | 6,745 |
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| EPS (cts) | 48.270 | 22.918% | 39.270 | 60.000 | 37.880 | 52.290 |
| DPS (cts) | 9.000 | -- | 6.500 | 9.500 | 5.000 | 8.500 |
| Dividend Payout Ratio (%) | 18.645% | -- | 16.552% | 15.833% | 13.200% | 16.255% |
| Cash flow per share ($) | 0.595 | -- | 0.667 | 0.710 | 0.518 | 0.402 |
| NBV per share ($) | 3.389 | -- | 3.029 | 3.013 | 2.472 | 2.071 |
| Remarks: | Real time quote last updated: 11/11/2024 10:58 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD 157,440,000 |
| %Change | -7.285% |
| EPS / (LPS) | HKD 0.277 |
| NBV Per Share ($) | HKD 3.551 |